Anti-epileptics Flashcards
What is the benefit on the intra-nasal route of administration for anti-epileptics
- No need for IV access
- Allows entry of drugs through nervous pathway (olfactive and trigeminal nerves) -> no blood-brain barrier to cross
- Also high absorption in circulation since highly vascularized epithelium
What is the therapeutic range of phenobarbital levels? When should levels be monitored?
Dogs: 25-35 mg/L = ~100-150 umol/L
Cats: 15-45 mg/L = 65-190 umol/L
Levels should be measured 2 weeks after starting or any change in dose, 6 weeks after starting, and then every 6 months
Mechanism of action of phenobarbital
- GABA-A receptor agonist ->prolongs opening of Cl channel -> hyperpolarization
- AMPA glutamate receptor antagonist
- Voltage-gated calcium channel inhibitor
Name 2 anticonvulsants that do not have hepatic metabolism
Bromide and levetiracetam (excreted unchanged in urine)
Which anticonvulsant has minimal protein binding
Levetiracetam
Mechanism of action of levetiracetam
Binds to synaptic vesicle proteins SV2A -> inhibits release of neurotransmitters
Mechanism of action of bromide
Bromide ions move intracellularly via chloride channel -> hyperpolarization
Mechanism of action of zonisamide
- Voltage-gated Na and T-type Ca channels inhibitor
- Modulation of dopaminergic activity
- GABA agonist
- Carbonic anhydrase inhibitor
When should serum levels be monitored after initiation of pheno / bromide / zonisamide
- Phenobarbital: 2 weeks
- Bromide: 6-12 weeks
- Zonisamide: 2 weeks
What are adverse effects of zonisamide
- Sedation, ataxia
- GI signs
- Idiosyncratic severe hepatotoxicity
- Tubular acidosis
- KCS
Name 3 anti-epileptics whose metabolism is enhanced by phenobarbital administration
- Phenobarbital
- Levetiracetam
- Zonisamide
What is the mechanism of action of CBD for its anticonvulsant effect
- Inhibition of glutamate via binding to transient receptor potential channels
- Activation of 5-HT1A receptors
- Inhibition of adenosine reuptake
List adverse effects of phenobarbital
- Sedation, ataxia
- PUPD
- Polyphagia
- Cardiovascular and respiratory depression (loading dose)
- Bone marrow suppression
- Hepatotoxicity
- Superficial dermatitis
- Pseudolymphoma
- Altered metabolism of other drugs
- Decreased T4 (without hypothyroidism)
- Increased ALP (without liver injury)
What are some considerations of diazepam that should be known when preparing for administration?
- Should not be stored in plastic syringes or infusion lines for any length of time (loses potency)
- Precoating the infusion lines with DZP before CRI administration is required
- Light sensitive
- Diluted in propylene glycol –> phlebitis and hypotension with rapid administration
List 2 neuroprotective properties of dexemdetomidine
- Decreases cerebral metabolic and oxygen demand
- Decreases brain edema via vasoconstriction + maintenance of MAP